Clinical Trial Update: SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial of SentoClone® for advanced malignant melanoma, comparing it to a reference treatment; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• SentoClone®

Snippet

Sponsor: SentoClone AB | Conditions: Malignant Melanoma | Phase 2 | Status: UNKNOWN